Abstract
We describe a comprehensive translational approach for identifying candidate genes for alcoholism. The approach relies on the cross-matching of animal model brain gene expression data with human genetic linkage data, as well as human tissue data and biological roles data, an approach termed convergent functional genomics. An analysis of three animal model paradigms, based on inbred alcohol-preferring (iP) and alcohol-non-preferring (iNP) rats, and their response to treatments with alcohol, was used. A comprehensive analysis of microarray gene expression data from five key brain regions (frontal cortex, amygdala, caudate–putamen, nucleus accumbens and hippocampus) was carried out. The Bayesian-like integration of multiple independent lines of evidence, each by itself lacking sufficient discriminatory power, led to the identification of high probability candidate genes, pathways and mechanisms for alcoholism. These data reveal that alcohol has pleiotropic effects on multiple systems, which may explain the diverse neuropsychiatric and medical pathology in alcoholism. Some of the pathways identified suggest avenues for pharmacotherapy of alcoholism with existing agents, such as angiotensin-converting enzyme (ACE) inhibitors. Experiments we carried out in alcohol-preferring rats with an ACE inhibitor show a marked modulation of alcohol intake. Other pathways are new potential targets for drug development. The emergent overall picture is that physical and physiological robustness may permit alcohol-preferring individuals to withstand the aversive effects of alcohol. In conjunction with a higher reactivity to its rewarding effects, they may able to ingest enough of this nonspecific drug for a strong hedonic and addictive effect to occur.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Accessions
GenBank/EMBL/DDBJ
References
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511–2518.
Muthen BO, Grant B, Hasin D . The dimensionality of alcohol abuse and dependence: factor analysis of DSM-III-R and proposed DSM-IV criteria in the 1988 National Health Interview Survey. Addiction 1993; 88: 1079–1090.
Lennox RD, Steele PD, Zarkin GA, Bray JW . The differential effects of alcohol consumption and dependence on adverse alcohol-related consequences: implications for the workforce. Drug Alcohol Depend 1998; 50: 211–220.
Koob GF . Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 2003; 27: 232–243.
Schuckit MA, Smith TL, Danko GP, Kramer J, Godinez J, Bucholz KK et al. Prospective evaluation of the four DSM-IV criteria for alcohol abuse in a large population. Am J Psychiatry 2005; 162: 350–360.
Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ . Family transmission and heritability of externalizing disorders: a twin-family study. Arch Gen Psychiatry 2004; 61: 922–928.
Tyndale RF . Genetics of alcohol and tobacco use in humans. Ann Med 2003; 35: 94–121.
Walters GD . The heritability of alcohol abuse and dependence: a meta-analysis of behavior genetic research. Am J Drug Alcohol Abuse 2002; 28: 557–584.
Oroszi G, Goldman D . Alcoholism: genes and mechanisms. Pharmacogenomics 2004; 5: 1037–1048.
McBride WJ, Kerns RT, Rodd ZA, Strother WN, Edenberg HJ, Hashimoto JG et al. Alcohol effects on central nervous system gene expression in genetic animal models. Alcohol Clin Exp Res 2005; 29: 167–175.
Worst TJ, Vrana KE . Alcohol and gene expression in the central nervous system. Alcohol Alcohol 2005; 40: 63–75.
Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO et al. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004; 74: 705–714.
Jones KA, Porjesz B, Almasy L, Bierut L, Goate A, Wang JC et al. Linkage and linkage disequilibrium of evoked EEG oscillations with CHRM2 receptor gene polymorphisms: implications for human brain dynamics and cognition. Int J Psychophysiol 2004; 53: 75–90.
Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S et al. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 2004; 13: 1903–1911.
Covault J, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR . Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet B 2004; 129: 104–109.
Lappalainen J, Krupitsky E, Remizov M, Pchelina S, Taraskina A, Zvartau E et al. Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res 2005; 29: 493–498.
Pierucci-Lagha A, Covault J, Feinn R, Nellissery M, Hernandez-Avila C, Oncken C et al. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride. Neuropsychopharmacology 2005; 30: 1193–1203.
Belfer I, Hipp H, McKnight C, Evans C, Buzas B, Bollettino A et al. Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 2006; 11: 301–311.
Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA . An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8–16.
Hinrichs AL, Wang JC, Bufe B, Kwon JM, Budde J, Allen R et al. Functional variant in a bitter-taste receptor (hTAS2R16) influences risk of alcohol dependence. Am J Hum Genet 2006; 78: 103–111.
Niculescu III AB, Segal DS, Kuczenski R, Barrett T, Hauger RL, Kelsoe JR . Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol Genomics 2000; 4: 83–91.
Niculescu III AB, Kelsoe JR . Convergent functional genomics: application to bipolar disorder. Ann Med 2001; 33: 263–271.
Kelsoe JR, Niculescu III AB . Finding genes for bipolar disorder in the functional genomics era: from convergent functional genomics to phenomics and back. CNS Spectr 2002; 7: 215–226.
Bertsch B, Ogden CA, Sidhu K, Le-Niculescu H, Kuczenski R, Niculescu AB . Convergent functional genomics: a Bayesian candidate gene identification approach for complex disorders. Methods 2005; 37: 274–279.
Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 2004; 9: 1007–1029.
Smith DG, Learn JE, McBride WJ, Lumeng L, Li TK, Murphy JM . Alcohol-naive alcohol-preferring (P) rats exhibit higher local cerebral glucose utilization than alcohol-nonpreferring (NP) and Wistar rats. Alcohol Clin Exp Res 2001; 25: 1309–1316.
Flatscher-Bader T, van der Brug M, Hwang JW, Gochee PA, Matsumoto I, Niwa S et al. Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics. J Neurochem 2005; 93: 359–370.
Oscar-Berman M, Marinkovic K . Alcoholism and the brain: an overview. Alcohol Res Health 2003; 27: 125–133.
Edenberg HJ, Strother WN, McClintick JN, Tian H, Stephens M, Jerome RE et al. Gene expression in the hippocampus of inbred alcohol-preferring and -nonpreferring rats. Genes Brain Behav 2005; 4: 20–30.
Rodd ZA, Bell RL, Melendez RI, Kuc KA, Lumeng L, Li TK et al. Comparison of intracranial self-administration of ethanol within the posterior ventral tegmental area between alcohol-preferring and Wistar rats. Alcohol Clin Exp Res 2004; 28: 1212–1219.
Sladka M, Kren V, Klir P . Spontaneous acute lymphoblastic leukemia in Sprague–Dawley rats. II. Cytogenetic analysis of nine individual leukemias. Neoplasma 1988; 35: 379–388.
Hamta A, Adamovic T, Heloua K, Levan G . Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization. Cancer Genet Cytogenet 2005; 159: 123–128.
Nurnberger Jr JI, Wiegand R, Bucholz K, O'Connor S, Meyer ET, Reich T et al. A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcohol-dependent probands. Arch Gen Psychiatry 2004; 61: 1246–1256.
Schuckit MA . Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 1986; 143: 140–147.
Maher BS, Marazita ML, Zubenko WN, Kaplan BB, Zubenko GS . Genetic segregation analysis of alcohol and other substance-use disorders in families with recurrent, early-onset major depression. Am J Drug Alcohol Abuse 2002; 28: 711–731.
Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K . Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 2004; 67: 157–166.
Brown ES . Bipolar disorder and substance abuse. Psychiatr Clin N Am 2005; 28: 415–425.
Lobb RR, Abraham WM, Burkly LC, Gill A, Ma W, Knight JA et al. Pathophysiologic role of alpha 4 integrins in the lung. Ann NY Acad Sci 1996; 796: 113–123.
Feigelson SW, Grabovsky V, Shamri R, Levy S, Alon R . The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow. J Biol Chem 2003; 278: 51203–51212.
Coppolino M, Migliorini M, Argraves WS, Dedhar S . Identification of a novel form of the alpha 3 integrin subunit: covalent association with transferrin receptor. Biochem J 1995; 306 (Part 1): 129–134.
Ponka P . Cell biology of heme. Am J Med Sci 1999; 318: 241–256.
Tamura K, Chen YE, Chen Q, Nyui N, Horiuchi M, Takasaki I et al. Expression of renin–angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor. Mol Cell Biochem 2000; 212: 203–209.
Traub O, Monia BP, Dean NM, Berk BC . PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells. J Biol Chem 1997; 272: 31251–31257.
Meyer A, van Golen CM, Kim B, van Golen KL, Feldman EL . Integrin expression regulates neuroblastoma attachment and migration. Neoplasia 2004; 6: 332–342.
Padovan CS, Jahn K, Birnbaum T, Reich P, Sostak P, Strupp M et al. Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant 2003; 12: 839–848.
Han S, Sidell N, Roman J . Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett 2005; 219: 71–81.
Shima T, Nada S, Okada M . Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts. Proc Natl Acad Sci USA 2003; 100: 14897–14902.
Wang L, Kwak JH, Kim SI, He Y, Choi ME . Transforming growth factor-beta1 stimulates vascular endothelial growth factor 164 via mitogen-activated protein kinase kinase 3-p38alpha and p38delta mitogen-activated protein kinase-dependent pathway in murine mesangial cells. J Biol Chem 2004; 279: 33213–33219.
Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS . Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 2000; 3: 323–329.
Naeve GS, Ramakrishnan M, Kramer R, Hevroni D, Citri Y, Theill LE . Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc Natl Acad Sci USA 1997; 94: 2648–2653.
Vendemiale G, Grattagliano I, Altomare E, Serviddio G, Portincasa P, Prigigallo F et al. Mitochondrial oxidative damage and myocardial fibrosis in rats chronically intoxicated with moderate doses of ethanol. Toxicol Lett 2001; 123: 209–216.
Savolainen V, Perola M, Lalu K, Penttila A, Virtanen I, Karhunen PJ . Early perivenular fibrogenesis – precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J Hepatol 1995; 23: 524–531.
Stenback F, Wasenius VM, Sotaniemi EA . Interstitial collagen in alcoholic human liver. Histol Histopathol 1987; 2: 401–411.
Ren LQ, Garrett DK, Syapin M, Syapin PJ . Differential fibronectin expression in activated C6 glial cells treated with ethanol. Mol Pharmacol 2000; 58: 1303–1309.
Bell RL, Stewart RB, Woods II JE, Lumeng L, Li TK, Murphy JM et al. Responsivity and development of tolerance to the motor impairing effects of moderate doses of ethanol in alcohol-preferring (P) and -nonpreferring (NP) rat lines. Alcohol Clin Exp Res 2001; 25: 644–650.
Hill SY, Shen S, Zezza N, Hoffman EK, Perlin M, Allan W . A genome wide search for alcoholism susceptibility genes. Am J Med Genet B 2004; 128: 102–113.
Paunio T, Tuulio-Henriksson A, Hiekkalinna T, Perola M, Varilo T, Partonen T et al. Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q. Hum Mol Genet 2004; 13: 1693–1702.
Miyamae M, Rodriguez MM, Camacho SA, Diamond I, Mochly-Rosen D, Figueredo VM . Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci USA 1998; 95: 8262–8267.
Mayfield RD, Lewohl JM, Dodd PR, Herlihy A, Liu J, Harris RA . Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem 2002; 81: 802–813.
Geisert Jr EE, Williams RW, Geisert GR, Fan L, Asbury AM, Maecker HT et al. Increased brain size and glial cell number in CD81-null mice. J Comp Neurol 2002; 453: 22–32.
Kelic S, Levy S, Suarez C, Weinstein DE . CD81 regulates neuron-induced astrocyte cell-cycle exit. Mol Cell Neurosci 2001; 17: 551–560.
Bahi A, Boyer F, Kafri T, Dreyer JL . CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirus. Eur J Neurosci 2004; 19: 1621–1633.
Michna L, Brenz Verca MS, Widmer DA, Chen S, Lee J, Rogove J et al. Altered sensitivity of CD81-deficient mice to neurobehavioral effects of cocaine. Brain Res Mol Brain Res 2001; 90: 68–74.
Michna L, Brenz-Verca M, Dreyer JL, Wagner GC . Methods to examine molecular changes and behavioral effects of drug administration. Brain Res Brain Res Protocol 2002; 9: 181–196.
Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, Moore E et al. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 1998; 81: 216–221.
Zandi PP, Willour VL, Huo Y, Chellis J, Potash JB, MacKinnon DF et al. Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Med Genet B 2003; 119: 69–76.
Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger Jr JI et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 2003; 73: 49–62.
DeVito WJ, Stone S . Prenatal exposure to ethanol alters the neuroimmune response to a central nervous system wound in the adult rat. Alcohol 2001; 25: 39–47.
Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD et al. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 1999; 91: 68–76.
Gruber-Olipitz M, Stevenson R, Olipitz W, Wagner E, Gesslbauer B, Kungl A et al. Transcriptional pattern analysis of adrenergic immunoregulation in mice. Twelve hours norepinephrine treatment alters the expression of a set of genes involved in monocyte activation and leukocyte trafficking. J Neuroimmunol 2004; 155: 136–142.
Lappalainen J, Kranzler HR, Petrakis I, Somberg LK, Page G, Krystal JH et al. Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus. Mol Psychiatry 2004; 9: 312–319.
Nurnberger Jr JI, Foroud T, Flury L, Su J, Meyer ET, Hu K et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 2001; 158: 718–724.
Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 1998; 81: 207–215.
Foroud T, Edenberg HJ, Goate A, Rice J, Flury L, Koller DL et al. Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin Exp Res 2000; 24: 933–945.
Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS . Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21–q22. Science 2000; 288: 678–682.
Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O'Brien JT . Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 2003; 18: 7–13.
McKinzie DL, Nowak KL, Murphy JM, Li TK, Lumeng L, McBride WJ . Development of alcohol drinking behavior in rat lines selectively bred for divergent alcohol preference. Alcohol Clin Exp Res 1998; 22: 1584–1590.
Rodd ZA, Bell RL, Sable HJ, Murphy JM, McBride WJ . Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav 2004; 79: 439–450.
Galaif ER, Newcomb MD . Predictors of polydrug use among four ethnic groups: a 12-year longitudinal study. Addict Behav 1999; 24: 607–631.
Ishiguro H, Liu QR, Gong JP, Hall FS, Ujike H, Morales M et al. NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology 2006; 31: 572–584.
Ho L, Guo Y, Spielman L, Petrescu O, Haroutunian V, Purohit D et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett 2001; 298: 191–194.
Golka K, Wiese A . Carbohydrate-deficient transferrin (CDT) – a biomarker for long-term alcohol consumption. J Toxicol Environ Health B 2004; 7: 319–337.
Suzuki Y, Saito H, Suzuki M, Hosoki Y, Sakurai S, Fujimoto Y et al. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res 2002; 26: 26S–31S.
Dick DM, Nurnberger Jr J, Edenberg HJ, Goate A, Crowe R, Rice J et al. Suggestive linkage on chromosome 1 for a quantitative alcohol-related phenotype. Alcohol Clin Exp Res 2002; 26: 1453–1460.
Maziade M, Roy MA, Chagnon YC, Cliche D, Fournier JP, Montgrain N et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatry 2005; 10: 486–499.
Devlin B, Bacanu SA, Roeder K, Reimherr F, Wender P, Galke B et al. Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol Psychiatry 2002; 7: 689–694.
Schosser A, Fuchs K, Leisch F, Bailer U, Meszaros K, Lenzinger E et al. Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29; a follow-up. J Psychiatr Res 2004; 38: 357–364.
Liu J, Lewohl JM, Dodd PR, Randall PK, Harris RA, Mayfield RD . Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human brain. J Neurochem 2004; 90: 1050–1058.
Podvinec M, Handschin C, Looser R, Meyer UA . Identification of the xenosensors regulating human 5-aminolevulinate synthase. Proc Natl Acad Sci USA 2004; 101: 9127–9132.
Teschke R, Gorys-Konemann C, Daldrup T, Goerz G . Influence of chronic alcohol consumption on hepatic heme and porphyrin metabolism. Biochem Pharmacol 1987; 36: 1133–1138.
Kaasik K, Lee CC . Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 2004; 430: 467–471.
Irwin MR, Rinetti G . Disordered sleep, nocturnal cytokines, and immunity: interactions between alcohol dependence and African-American ethnicity. Alcohol 2004; 32: 53–61.
Sarviharju M, Riikonen J, Jaatinen P, Sinclair D, Hervonen A, Kiianmaa K . Survival of AA and ANA rats during lifelong ethanol exposure. Alcohol Clin Exp Res 2004; 28: 93–97.
Lucas DL, Brown RA, Wassef M, Giles TD . Alcohol and the cardiovascular system research challenges and opportunities. J Am Coll Cardiol 2005; 45: 1916–1924.
Coe IR, Yao L, Diamond I, Gordon AS . The role of protein kinase C in cellular tolerance to ethanol. J Biol Chem 1996; 271: 29468–29472.
Gordon AS, Yao L, Jiang Z, Fishburn CS, Fuchs S, Diamond I . Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C. Mol Pharmacol 2001; 59: 153–160.
Choi DS, Wang D, Dadgar J, Chang WS, Messing RO . Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J Neurosci 2002; 22: 9905–9911.
Zhou HZ, Karliner JS, Gray MO . Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol 2002; 283: H165–H174.
Mulligan MK, Ponomarev I, Hitzemann RJ, Belknap JK, Tabakoff B, Harris RA et al. Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. Proc Natl Acad Sci USA 2006; 103: 6368–6373.
Li X, Jope RS . Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J Neurochem 1995; 65: 2500–2508.
Maul B, Siems WE, Hoehe MR, Grecksch G, Bader M, Walther T . Alcohol consumption is controlled by angiotensin II. FASEB J 2001; 15: 1640–1642.
Maul B, Krause W, Pankow K, Becker M, Gembardt F, Alenina N et al. Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J 2005; 19: 1474–1481.
Lingham T, Perlanski E, Grupp LA . Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. Alcohol Clin Exp Res 1990; 14: 92–99.
Sun Z, Cade R, Zhang Z, Alouidor J, Van H . Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension 2003; 41: 322–327.
Meira-Lima IV, Pereira AC, Mota GF, Krieger JE, Vallada H . Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans. Neurosci Lett 2000; 293: 103–106.
Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, Martin R et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 2001; 10: 1611–1617.
Hoffman PL, Miles M, Edenberg HJ, Sommer W, Tabakoff B, Wehner JM et al. Gene expression in brain: a window on ethanol dependence, neuroadaptation, and preference. Alcohol Clin Exp Res 2003; 27: 155–168.
Arlinde C, Sommer W, Bjork K, Reimers M, Hyytia P, Kiianmaa K et al. A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J 2004; 4: 208–218.
Sommer W, Arlinde C, Heilig M . The search for candidate genes of alcoholism: evidence from expression profiling studies. Addict Biol 2005; 10: 71–79.
Wyszynski DF, Panhuysen CI, Ma Q, Yip AG, Wilcox M, Erlich P et al. Genome-wide screen for heavy alcohol consumption. BMC Genet 2003; 4 (Suppl 1): S106.
Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D et al. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 2003; 73: 601–611.
Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T . Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 2004; 9: 406–416.
Renkawek K, Bosman GJ, de Jong WW . Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol (Berlin) 1994; 87: 511–519.
Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y, Amagasa T . Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer 2005; 104: 2709–2716.
Granot-Attas S, Elson A . Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells. Exp Cell Res 2004; 294: 236–243.
Jiang Y, Wang L, Gong W, Wei D, Le X, Yao J et al. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metast 2004; 21: 755–764.
Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604–5609.
Yamada K, Iwayama-Shigeno Y, Yoshida Y, Toyota T, Itokawa M, Hattori E et al. Family-based association study of schizophrenia with 444 markers and analysis of a new susceptibility locus mapped to 11q13.3. Am J Med Genet B 2004; 127: 11–19.
Schuckit MA, Edenberg HJ, Kalmijn J, Flury L, Smith TL, Reich T et al. A genome-wide search for genes that relate to a low level of response to alcohol. Alcohol Clin Exp Res 2001; 25: 323–329.
Ehlers CL, Spence JP, Wall TL, Gilder DA, Carr LG . Association of ALDH1 promoter polymorphisms with alcohol-related phenotypes in southwest California Indians. Alcohol Clin Exp Res 2004; 28: 1481–1486.
Spence JP, Liang T, Eriksson CJ, Taylor RE, Wall TL, Ehlers CL et al. Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations. Alcohol Clin Exp Res 2003; 27: 1389–1394.
Galter D, Buervenich S, Carmine A, Anvret M, Olson L . ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis 2003; 14: 637–647.
Kim JS, Kim YJ, Kim TY, Song JY, Cho YH, Park YC et al. Association of ALDH2 polymorphism with sensitivity to acetaldehyde-induced micronuclei and facial flushing after alcohol intake. Toxicology 2005; 210: 169–174.
Samigullin D, Bill CA, Coleman WL, Bykhovskaia M . Regulation of transmitter release by synapsin II in mouse motor terminals. J Physiol 2004; 561: 149–158.
Chen Q, He G, Wang XY, Chen QY, Liu XM, Gu ZZ et al. Positive association between synapsin II and schizophrenia. Biol Psychiatry 2004; 56: 177–181.
Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P . Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53–67.
Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ . Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 571–578.
Grebb JA, Greengard P . An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults. Arch Gen Psychiatry 1990; 47: 1149–1156.
Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B 2006; 141: 387–393.
McGough NN, He DY, Logrip ML, Jeanblanc J, Phamluong K, Luong K et al. RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci 2004; 24: 10542–10552.
MacLennan AJ, Lee N, Walker DW . Chronic ethanol administration decreases brain-derived neurotrophic factor gene expression in the rat hippocampus. Neurosci Lett 1995; 197: 105–108.
Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM . Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143–148.
Matsushita S, Kimura M, Miyakawa T, Yoshino A, Murayama M, Masaki T et al. Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin Exp Res 2004; 28: 1609–1612.
Hashimoto K, Shimizu E, Iyo M . Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45: 104–114.
Strauss J, Barr CL, George CJ, Devlin B, Vetro A, Kiss E et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry 2005; 10: 861–867.
Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B 2004; 131: 16–19.
Muglia P, Vicente AM, Verga M, King N, Macciardi F, Kennedy JL . Association between the BDNF gene and schizophrenia. Mol Psychiatry 2003; 8: 146–147.
Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579–593.
Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV et al. Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry 2003; 8: 241–245.
Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF . Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004; 9: 609–620, 544.
Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN . Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60: 804–815.
Webster MJ, O'Grady J, Kleinman JE, Weickert CS . Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005; 133: 453–461.
Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ . Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 2002; 70: 462–473.
Yang X, Oswald L, Wand G . The cyclic AMP/protein kinase A signal transduction pathway modulates tolerance to sedative and hypothermic effects of ethanol. Alcohol Clin Exp Res 2003; 27: 1220–1225.
Plagge A, Isles AR, Gordon E, Humby T, Dean W, Gritsch S et al. Imprinted Nesp55 influences behavioral reactivity to novel environments. Mol Cell Biol 2005; 25: 3019–3026.
Lobos EA, Todd RD . Cladistic analysis of disease association with tyrosine hydroxylase: application to manic-depressive disease and alcoholism. Am J Med Genet 1997; 74: 289–295.
Todd RD, Lobos EA, Parsian A, Simpson S, DePaulo JR . Manic-depressive illness and tyrosine hydroxylase markers. Bipolar Disorder Working Group. Lancet 1996; 347: 1634.
Biegon A, Fieldust S . Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims. Synapse 1992; 10: 79–82.
Farren CK, Dinan TG . Alcoholism and typology: findings in an Irish private hospital population. J Stud Alcohol 1996; 57: 249–252.
Akiskal HS . Toward a definition of generalized anxiety disorder as an anxious temperament type. Acta Psychiatr Scand Suppl 1998; 393: 66–73.
Muhlin GL . Ethnic differences in alcohol misuse: a striking reaffirmation. J Stud Alcohol 1985; 46: 172–173.
Rosenwaike I, Hempstead K . Differential mortality by ethnicity: foreign-born Irish, Italians and Jews in New York City, 1979–81. Soc Sci Med 1989; 29: 885–889.
Greenslade L, Pearson M, Madden M . A good man's fault: alcohol and Irish people at home and abroad. Alcohol Alcohol 1995; 30: 407–417.
Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ et al. PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet B 2006; 141: 653–662.
Murphy JM, Stewart RB, Bell RL, Badia-Elder NE, Carr LG, McBride WJ et al. Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav Genet 2002; 32: 363–388.
Stewart RB, Li TK . The neurobiology of alcoholism in genetically selected rat models. Alcohol Health Res World 1997; 21: 169–176.
McBride WJ, Li TK . Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 1998; 12: 339–369.
Li TK, Lumeng L, McBride WJ, Murphy JM . Rodent lines selected for factors affecting alcohol consumption. Alcohol Alcohol 1987 (Suppl 1): 91–96.
Bozarth MA, Gerber GJ, Wise RA . Intracranial self-stimulation as a technique to study the reward properties of drugs of abuse. Pharmacol Biochem Behav 1980; 13 (Suppl 1): 245–247.
Goeders NE, Smith JE . Intracranial self-administration methodologies. Neurosci Biobehav Rev 1987; 11: 319–329.
Bozarth MA, Wise RA . Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 1981; 28: 551–555.
Devine DP, Wise RA . Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 1994; 14: 1978–1984.
Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L . Self-injection of amphetamine directly into the brain. Psychopharmacology (Berlin) 1983; 81: 158–163.
Goeders NE, Smith JE . Reinforcing properties of cocaine in the medical prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 1986; 25: 191–199.
Rodd-Henricks ZA, McKinzie DL, Crile RS, Murphy JM, McBride WJ . Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats. Psychopharmacology (Berlin) 2000; 149: 217–224.
Gonzales RA, Job MO, Doyon WM . The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther 2004; 103: 121–146.
McClintick JN, Jerome RE, Nicholson CR, Crabb DW, Edenberg HJ . Reproducibility of oligonucleotide arrays using small samples. BMC Genomics 2003; 4: 4.
Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21–22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3–24 and 20q12.1–11.23. Am J Hum Genet 2001; 68: 661–673.
Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001; 10: 2933–2944.
Lindholm E, Aberg K, Ekholm B, Pettersson U, Adolfsson R, Jazin EE . Reconstruction of ancestral haplotypes in a 12-generation schizophrenia pedigree. Psychiatr Genet 2004; 14: 1–8.
Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 1999; 88: 567–587.
George AJ, Holsinger RM, McLean CA, Tan SS, Scott HS, Cardamone T et al. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Aging 2006; 27: 614–623.
Vasiliou V, Pappa A . Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology 2000; 61: 192–198.
Macgregor S, Visscher PM, Knott SA, Thomson P, Porteous DJ, Millar JK et al. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry 2004; 9: 1083–1090.
Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA . Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin Exp Res 2000; 24: 1873–1882.
Brecher AS, Riley C, Basista MH . Acetaldehyde-modified lysozyme function: its potential implication in the promotion of infection in alcoholics. Alcohol 1995; 12: 169–172.
Rodriguez Parkitna JM, Bilecki W, Mierzejewski P, Stefanski R, Ligeza A, Bargiela A et al. Effects of morphine on gene expression in the rat amygdala. J Neurochem 2004; 91: 38–48.
Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN . Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 1999; 34: 21–29.
Paunio T, Shen S, Zezza N, Perola M, Perlin M, Allan W . Search for alcoholism susceptibility genes. Hum Mol Genet 2004; 13: 102–113.
Yang SQ, Lin HZ, Yin M, Albrecht JH, Diehl AM . Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol 1998; 275: G696–G704.
Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002; 62: 4491–4498.
Smith MZ, Nagy Z, Esiri MM . Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci Lett 1999; 271: 45–48.
Olive MF, Mehmert KK, Messing RO, Hodge CW . Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur J Neurosci 2000; 12: 4131–4140.
Matsushima H, Shimohama S, Chachin M, Taniguchi T, Kimura J . Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease. J Neurochem 1996; 67: 317–323.
Huang Y, Wang KK . The calpain family and human disease. Trends Mol Med 2001; 7: 355–362.
Rimondini R, Arlinde C, Sommer W, Heilig M . Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 2002; 16: 27–35.
Rivier C, Lee S . Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Brain Res 1996; 726: 1–10.
Peck JA, Stopa EG . Agrin and microvascular damage in Alzheimer's disease. Med Health R I 2002; 85: 202–206.
Maziade M, Bissonnette L, Rouillard E, Martinez M, Turgeon M, Charron L et al. 6p24-22 region and major psychoses in the Eastern Quebec population. Le Groupe IREP. Am J Med Genet 1997; 74: 311–318.
Moises HW, Zoega T, Gottesman II . The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002; 2: 8.
Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL et al. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 2004; 138: 173–188.
Kohn Y, Danilovich E, Filon D, Oppenheim A, Karni O, Kanyas K et al. Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysis. Am J Med Genet B 2004; 128: 65–70.
Lerer B, Segman RH, Hamdan A, Kanyas K, Karni O, Kohn Y et al. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol Psychiatry 2003; 8: 488–498.
Sun F, Cheng R, Flanders WD, Yang Q, Khoury MJ . Whole genome association studies for genes affecting alcohol dependence. Genet Epidemiol 1999; 17 (Suppl 1): S337–S342.
Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999; 65: 1114–1124.
Bezchlibnyk YB, Wang JF, McQueen GM, Young LT . Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem 2001; 79: 826–834.
Schumacher AM, Schavocky JP, Velentza AV, Mirzoeva S, Watterson DM . A calmodulin-regulated protein kinase linked to neuron survival is a substrate for the calmodulin-regulated death-associated protein kinase. Biochemistry 2004; 43: 8116–8124.
Tsai SY, Lee HC, Chen CC, Lee CH . Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission. J Psychiatr Res 2003; 37: 229–235.
Treadwell JA, Pagniello KB, Singh SM . Genetic segregation of brain gene expression identifies retinaldehyde binding protein 1 and syntaxin 12 as potential contributors to ethanol preference in mice. Behav Genet 2004; 34: 425–439.
Sokolov BP, Jiang L, Trivedi NS, Aston C . Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res 2003; 72: 756–767.
Hayase T, Yamamoto Y, Yamamoto K, Muso E, Shiota K . Stressor-like effects of cocaine on heat shock protein and stress-activated protein kinase expression in the rat hippocampus: interaction with ethanol and anti-toxicity drugs. Leg Med (Tokyo) 2003; 5 (Suppl 1): S87–S90.
Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen-White KR, Rosso A et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatry 2002; 7: 851–859.
Karege F, Schwald M, Papadimitriou P, Lachausse C, Cisse M . The cAMP-dependent protein kinase A and brain-derived neurotrophic factor expression in lymphoblast cells of bipolar affective disorder. J Affect Disord 2004; 79: 187–192.
Karege F, Schwald M, El Kouaissi R . Drug-induced decrease of protein kinase a activity reveals alteration in BDNF expression of bipolar affective disorder. Neuropsychopharmacology 2004; 29: 805–812.
Williams JT, Begleiter H, Porjesz B, Edenberg HJ, Foroud T, Reich T et al. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials. Am J Hum Genet 1999; 65: 1148–1160.
Hasegawa H, Osada K, Misonoo A, Morinobu S, Yamamoto H, Miyamoto E et al. Chronic carbamazepine treatment increases myristoylated alanine-rich C kinase substrate phosphorylation in the rat cerebral cortex via down-regulation of calcineurin A alpha. Brain Res 2003; 994: 19–26.
Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 2001; 98: 585–590.
Nanji AA, Lau GK, Tipoe GL, Yuen ST, Chen YX, Thomas P et al. Macrophage migration inhibitory factor expression in male and female ethanol-fed rats. J Interferon Cytokine Res 2001; 21: 1055–1062.
Oyama R, Yamamoto H, Titani K . Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation. Biochim Biophys Acta 2000; 1479: 91–102.
Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S . Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004; 61: 300–308.
Carmiel-Haggai M, Cederbaum AI, Nieto N . Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 2003; 125: 1818–1833.
Horvath B, Spies C, Horvath G, Kox WJ, Miyamoto S, Barry S et al. Uncoupling protein 2 (UCP2) lowers alcohol sensitivity and pain threshold. Biochem Pharmacol 2002; 64: 369–374.
Sriram K, Benkovic SA, Miller DB, O'Callaghan JP . Obesity exacerbates chemically induced neurodegeneration. Neuroscience 2002; 115: 1335–1346.
Guzman M, Castro J . Alterations in the regulatory properties of hepatic fatty acid oxidation and carnitine palmitoyltransferase I activity after ethanol feeding and withdrawal. Alcohol Clin Exp Res 1990; 14: 472–477.
Ewald H, Flint T, Kruse TA, Mors O . A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22–21, 4p16, 6q14–22, 10q26 and 16p13.3. Mol Psychiatry 2002; 7: 734–744.
Thomas AJ, Davis S, Ferrier IN, Kalaria RN, O'Brien JT . Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry 2004; 55: 652–655.
Schumann G, Rujescu D, Kissling C, Soyka M, Dahmen N, Preuss UW et al. Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts. Biol Psychiatry 2003; 54: 1422–1426.
Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL et al. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet 2003; 73: 107–114.
Miyakawa T, Yagi T, Kitazawa H, Yasuda M, Kawai N, Tsuboi K et al. Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science 1997; 278: 698–701.
Ohnuma T, Kato H, Arai H, McKenna PJ, Emson PC . Expression of Fyn, a non-receptor tyrosine kinase in prefrontal cortex from patients with schizophrenia and its correlation with clinical onset. Brain Res Mol Brain Res 2003; 112: 90–94.
Pecherskaya A, Rubin E, Solem M . Alterations in insulin-like growth factor-I signaling in cardiomyocytes from chronic alcohol-exposed rats. Alcohol Clin Exp Res 2002; 26: 995–1002.
Jafferali S, Dumont Y, Sotty F, Robitaille Y, Quirion R, Kar S . Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains. Synapse 2000; 38: 450–459.
Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA et al. Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet 2001; 10: 3037–3048.
Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C et al. Genome-wide scan in Portuguese Island families identifies 5q31–5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 2004; 9: 213–218.
Turner RT, Evans GL, Zhang M, Sibonga JD . Effects of parathyroid hormone on bone formation in a rat model for chronic alcohol abuse. Alcohol Clin Exp Res 2001; 25: 667–671.
Ikemoto M, Takita M, Imamura T, Inoue K . Increased sensitivity to the stimulant effects of morphine conferred by anti-adhesive glycoprotein SPARC in amygdala. Nat Med 2000; 6: 910–915.
Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L et al. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet 1994; 8: 291–296.
Solomon LR, Hillman RS . Vitamin B6 metabolism in anaemic and alcoholic man. Br J Haematol 1979; 41: 343–356.
Butterfield DA, Castegna A, Lauderback CM, Drake J . Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002; 23: 655–664.
Blennow K . CSF biomarkers for mild cognitive impairment. J Intern Med 2004; 256: 224–234.
Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P . Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berlin) 2001; 102: 373–379.
Miller BE, Whetsell Jr WO, Chong JK, Ghanbari HA . Distribution of Alzheimer's disease-associated protein (ADAP) in 10 human brains. J Neuropsychiatry Clin Neurosci 1992; 4: 303–307.
Lu KP . Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem Sci 2004; 29: 200–209.
Ma JZ, Zhang D, Dupont RT, Dockter M, Elston RC, Li MD . Mapping susceptibility loci for alcohol consumption using number of grams of alcohol consumed per day as a phenotype measure. BMC Genet 2003; 4 (Suppl 1): S104.
Sieg I, Doss MO, Kandels H, Schneider J . Effect of alcohol on delta-aminolevulinic acid dehydratase and porphyrin metabolism in man. Clin Chim Acta 1991; 202: 211–218.
Maes M, Lin A, Bonaccorso S, Vandoolaeghe E, Song C, Goossens F et al. Lower activity of serum peptidases in abstinent alcohol-dependent patients. Alcohol 1999; 17: 1–6.
Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T et al. Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. Chem Pharm Bull (Tokyo) 1990; 38: 1748–1749.
Foroud T, Bucholz KK, Edenberg HJ, Goate A, Neuman RJ, Porjesz B et al. Linkage of an alcoholism-related severity phenotype to chromosome 16. Alcohol Clin Exp Res 1998; 22: 2035–2042.
Takata K, Kitamura Y, Kakimura J, Shibagaki K, Tsuchiya D, Taniguchi T et al. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem Biophys Res Commun 2003; 301: 699–703.
Sheffield LJ, Knauert MP, Pakstis AJ, Zhao H, Kidd KK . Analyses of the COGA data set in one ethnic group with examinations of alternative definitions of alcoholism. Genet Epidemiol 1999; 17 (Suppl 1): S319–S324.
Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P . Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology 1986; 6: 608–614.
Dahmen N, Volp M, Singer P, Hiemke C, Szegedi A . Tyrosine hydroxylase Val-81-Met polymorphism associated with early-onset alcoholism. Psychiatr Genet 2005; 15: 13–16.
Sander T, Harms H, Rommelspacher H, Hoehe M, Schmidt LG . Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. Psychiatr Genet 1998; 8: 13–17.
Massat I, Souery D, Del-Favero J, Oruc L, Noethen MM, Blackwood D et al. Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol Psychiatry 2002; 7: 201–207.
Patterson-Buckendahl P, Blakley G, Kubovcakova L, Krizanova O, Pohorecky LA, Kvetnansky R . Alcohol alters rat adrenomedullary function and stress response. Ann NY Acad Sci 2004; 1018: 173–182.
Bassetti CL, Hersberger M, Baumann CR . CSF prostaglandin D synthase is reduced in excessive daytime sleepiness. J Neurol 2006 April 5 (Epub ahead of print).
Zhu Y, Fillenwarth MJ, Crabb D, Lumeng L, Lin RC . Identification of the 37-kd rat liver protein that forms an acetaldehyde adduct in vivo as delta 4-3-ketosteroid 5 beta-reductase. Hepatology 1996; 23: 115–122.
Ordway GA, Smith KS, Haycock JW . Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J Neurochem 1994; 62: 680–685.
Javors MA, Houston JP, Bowden CL . EGTA-extractable calmodulin in platelet membrane is lower in alcoholics than in controls. Alcohol 1985; 2: 433–436.
Ye XF, Lu Y, Zhang P, Liang JH . Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats. Eur J Pharmacol 2004; 486: 265–271.
Choi IG, Kee BS, Son HG, Ham BJ, Yang BH, Kim SH et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur Neuropsychopharmacol 2005; 3: 4.
Chai YG, Oh DY, Chung EK, Kim GS, Kim L, Lee YS et al. Alcohol and aldehyde dehydrogenase polymorphisms in men with type I and Type II alcoholism. Am J Psychiatry 2005; 162: 1003–1005.
Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 2004; 28: 374–384.
Tritos N, Kitraki E, Philippidis H, Stylianopoulou F . Neurotransmitter modulation of glucocorticoid receptor mRNA levels in the rat hippocampus. Neuroendocrinology 1999; 69: 324–330.
Khan MM, Parikh VV, Mahadik SP . Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J Neurochem 2003; 86: 1089–1100.
Acknowledgements
We would like to acknowledge our debt of gratitude to the efforts and results of the Collaborative Genetics of Alcoholism (COGA) consortium, and to the pioneering efforts to develop inbred alcohol preferring and non-preferring rat lines by T-K Li, L Lumeng and collaborators at Indiana University. This work was supported by funds from INGEN (Indiana Genomics Initiative at Indiana University) to ABN. This work was also supported by the Indiana Alcohol Research Center through P60AA007611 and the Integrative Neuroscience Initiative in Alcoholism through U01AA013518 (HJE, ZAR, WJM). Microarray data were generated in the Center for Medical Genomics at Indiana University School of Medicine, which is supported in part by INGEN (HJE). ABN would also like to thank Marc Schuckit for excellent clinical mentorship and introduction to the alcohol research field.
Author information
Authors and Affiliations
Corresponding author
Additional information
Duality of Interest
The authors declare that they have no competing financial interests.
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)
Supplementary information
Rights and permissions
About this article
Cite this article
Rodd, Z., Bertsch, B., Strother, W. et al. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. Pharmacogenomics J 7, 222–256 (2007). https://doi.org/10.1038/sj.tpj.6500420
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500420
Keywords
This article is cited by
-
Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report
Translational Psychiatry (2016)
-
Genetic risk prediction and neurobiological understanding of alcoholism
Translational Psychiatry (2014)
-
Convergent functional genomics in addiction research - a translational approach to study candidate genes and gene networks
In Silico Pharmacology (2013)
-
Discovery and validation of blood biomarkers for suicidality
Molecular Psychiatry (2013)
-
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction
Molecular Psychiatry (2012)